Leandro Sigman

Leandro Sigman serves as Chairman of Chemo, a global corporation specializing in the research, development, and manufacturing of pharmaceutical products, with a turnover of $1.5 billion and over 5,500 employees across various regions. Since 2016, Leandro has also held the position of CEO and Founder of Doctor24, an innovative e-health platform aimed at enhancing patient support through technology. Prior experience includes serving as Managing Director at Laboratorio Elea, where strategic growth in the gynecology sector was achieved, and as a Marketing Manager at Parke Davis, contributing to the development of notable pharmaceutical products. Educational qualifications include an MBA from IAE Business School and a General Management Program from IESE Business School, complemented by a Bachelor's degree in Economics and Journalism from the University of Buenos Aires and Taller Escuela Agencia, respectively.